Synthesis and Antimicrobial Evaluation of 1-[(2-Substituted phenyl)carbamoyl]naphthalen-2-yl Carbamates
- PMID: 27617988
- PMCID: PMC6273964
- DOI: 10.3390/molecules21091189
Synthesis and Antimicrobial Evaluation of 1-[(2-Substituted phenyl)carbamoyl]naphthalen-2-yl Carbamates
Abstract
Series of thirteen 1-[(2-chlorophenyl)carbamoyl]naphthalen-2-yl carbamates and thirteen 1-[(2-nitrophenyl)carbamoyl]naphthalen-2-yl carbamates with alkyl/cycloalkyl/arylalkyl chains were prepared and characterized. Primary in vitro screening of the synthesized compounds was performed against Staphylococcus aureus, two methicillin-resistant S. aureus strains, Mycobacterium marinum, and M. kansasii. 1-[(2-Chlorophenyl)carbamoyl]naphthalen-2-yl ethylcarbamate and 1-[(2-nitrophenyl)carbamoyl]naphthalen-2-yl ethylcarbamate showed antistaphylococcal (MICs = 42 µM against MRSA) and antimycobacterial (MICs = 21 µM) activity against the tested strains comparable with or higher than that of the standards ampicillin and isoniazid. In the case of bulkier carbamate tails (R > propyl/isopropyl), the activity was similar (MICs ca. 70 µM). Screening of the cytotoxicity of both of the most effective compounds was performed using THP-1 cells, and no significant lethal effect was observed (LD50 >30 µM). The structure-activity relationships are discussed.
Keywords: carbamates; hydroxynaphthalene-carboxamides; in vitro antibacterial activity; in vitro antimycobacterial activity; in vitro cytotoxicity assay; structure-activity relationships.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



References
-
- World Health Organization . World Health Statistics 2016: Monitoring Health for the SDGs. WHO Press; Geneva, Switzerland: 2016.
-
- World Health Organization . Global Tuberculosis Report 2015. WHO Press; Geneva, Switzerland: 2015.
-
- World Health Organization . Global Antimicrobial Resistance Surveillance System 2015. WHO Press; Geneva, Switzerland: 2015.
-
- European Centre for Disease Prevention and Control. [(accessed on 30 July 2016)]. Available online: http://ecdc.europa.eu/en/Pages/home.aspx.
-
- Thampi N., Showler A., Burry L., Bai A.D., Steinberg M., Ricciuto D.R., Bell C.M., Morris A.M. Multicenter study of health care cost of patients admitted to hospital with Staphylococcus aureus bacteremia: Impact of length of stay and intensity of care. Am. J. Infect. Control. 2015;43:739–744. doi: 10.1016/j.ajic.2015.01.031. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical